Literature DB >> 17543339

Surgical site infections in plastic surgery: an italian multicenter study.

Cecilia M J Drapeau1, Carlo D'Aniello, Anna Brafa, Emanuele Nicastri, Alessandro Silvestri, Giuseppe Nisi, Nicola Petrosillo.   

Abstract

BACKGROUND: Plastic surgery interventions have increased in terms of frequency, complexity of surgical procedures, and postoperative complications, particularly surgical site infections (SSIs). The aim of the present study was to assess the SSI frequency in plastic and reconstructive surgery settings in Italy and to evaluate the associated risk factors.
METHODS: From June 2004 to June 2005, a prospective multicenter study including 2806 consecutive patients was conducted in 23 Italian plastic and reconstructive units. To assess potential risk factors for surgical site infection, a conditional logistic regression model was used and results were exposed in terms of odds ratio (OR) with their respective 95% confidence interval (CI).
RESULTS: SSIs occurred in 85/2806 (3%) patients. Sixty (70.6%), 24 (28.2%), and 1 (1.2%) SSIs were classified as superficial, deep, and organ/space, respectively. Sixty-six percent of the SSIs were diagnosed during postdischarge surveillance. At multivariate analysis, diabetes mellitus, chronic obstructive pulmonary disease, preoperative radiotherapy, and use of surgical drains were significantly associated with the occurrence of SSI.
CONCLUSIONS: Our findings, based on a large population including all types of plastic and reconstructive interventions, provided consistent information on potential risk factors for SSI in this surgical setting. Moreover, the high rate of SSI found during the postdischarge surveillance underlines the need for improving active surveillance methodologies in this surgical setting.

Entities:  

Mesh:

Year:  2007        PMID: 17543339     DOI: 10.1016/j.jss.2007.01.040

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Decreasing expander breast infection: A new drain care protocol.

Authors:  John D Murray; Eric T Elwood; Glyn E Jones; Rebecca Barrick; Jack Feng
Journal:  Can J Plast Surg       Date:  2009

Review 2.  Comparison of Flap Fixation to Its Bed and Conventional Wound Closure with Drainage in Preventing Seroma Formation Following Mastectomy for Breast Cancer: Systematic Review and Meta-analysis.

Authors:  Di Rao; Juan Xie; Yijun Xia; Dongsheng Cao
Journal:  Aesthetic Plast Surg       Date:  2022-02-28       Impact factor: 2.708

3.  Healthcare-associated infections and the distribution of causative pathogens in patients with diabetes mellitus.

Authors:  N Erben; I Ozgunes; F Aksit; E Doyuk Kartal; E Colak; G Usluer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

Review 4.  The Global Prevalence of Seroma After Abdominoplasty: A Systematic Review and Meta-Analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Mohammadbagher Heydari; Masoud Mohammadi; Mahvan Hemmati; Shamarina Shohaimi
Journal:  Aesthetic Plast Surg       Date:  2021-06-02       Impact factor: 2.708

5.  A Prospective, Randomized, Multicenter Trial Assessing a Novel Lysine-Derived Urethane Adhesive in a Large Flap Surgical Procedure without Drains.

Authors:  Joseph P Hunstad; Joseph Michaels; A Jay Burns; Sheri Slezak; W Grant Stevens; Dottie M Clower; J Peter Rubin
Journal:  Aesthetic Plast Surg       Date:  2015-06-05       Impact factor: 2.326

6.  The Relationship between Preoperative Wound Classification and Postoperative Infection: A Multi-Institutional Analysis of 15,289 Patients.

Authors:  Lauren M Mioton; Sumanas W Jordan; Philip J Hanwright; Karl Y Bilimoria; John Ys Kim
Journal:  Arch Plast Surg       Date:  2013-09-13

7.  Lysine-urethane-based tissue adhesion for mastectomy-an approach to reducing the seroma rate?

Authors:  B Boeer; J Schneider; B Schoenfisch; C Röhm; S Paepke; E Oberlechner; R Ohlinger; A Hartkopf; S Y Brucker; M Hahn; M Marx
Journal:  Arch Gynecol Obstet       Date:  2020-11-04       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.